Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis.

Kim T, Giuliano AE, Lyman GH.

Cancer. 2006 Jan 1;106(1):4-16. Review.

2.

Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis.

Kelly AM, Dwamena B, Cronin P, Carlos RC.

Acad Radiol. 2009 May;16(5):551-63. doi: 10.1016/j.acra.2009.01.026. Review.

PMID:
19345896
3.

Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma.

Chua B, Ung O, Taylor R, Bilous M, Salisbury E, Boyages J.

Cancer. 2001 Oct 1;92(7):1769-74.

PMID:
11745248
4.
5.

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.

Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR.

Ann Surg Oncol. 2004 Sep;11(9):846-53. Epub 2004 Aug 16.

PMID:
15313737
6.

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.

Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK.

Cancer. 2007 Apr 1;109(7):1255-63.

7.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
8.

Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.

Cox C, White L, Allred N, Meyers M, Dickson D, Dupont E, Cantor A, Ly Q, Dessureault S, King J, Nicosia S, Vrcel V, Diaz N.

Ann Surg Oncol. 2006 May;13(5):708-11. Epub 2006 Mar 16.

PMID:
16538416
9.

Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.

Bassi KK, Seenu V, Ballehaninna UK, Parshad R, Chumber S, Dhar A, Gupta SD, Kumar R, Srivastava A.

Indian J Cancer. 2006 Jul-Sep;43(3):103-9.

10.
11.

Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.

Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A.

Eur J Surg Oncol. 2006 Feb;32(1):29-33. Epub 2005 Nov 2.

PMID:
16269227
12.

Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.

Jinno H, Sakata M, Asaga S, Wada M, Shimada T, Kitagawa Y, Suzuki T, Nakahara T, Kitamura N, Kubo A, Mukai M, Ikeda T, Kitajima M.

Breast J. 2008 Nov-Dec;14(6):551-5. doi: 10.1111/j.1524-4741.2008.00646.x. Epub 2008 Oct 13.

PMID:
19000054
13.
14.

A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.

Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, Renier M, Racano C, Carraro P, Nitti D; GIVOM Trialists.

Ann Surg. 2008 Feb;247(2):207-13. doi: 10.1097/SLA.0b013e31812e6a73.

PMID:
18216523
15.

Sentinel lymph node biopsy is successful and accurate in male breast carcinoma.

Flynn LW, Park J, Patil SM, Cody HS 3rd, Port ER.

J Am Coll Surg. 2008 Apr;206(4):616-21. doi: 10.1016/j.jamcollsurg.2007.11.005. Epub 2008 Feb 21.

PMID:
18387465
16.

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.

Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J.

Ann Surg Oncol. 2008 May;15(5):1316-21. doi: 10.1245/s10434-007-9759-z. Epub 2008 Mar 1.

PMID:
18311507
17.

Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.

Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC, Newman LA.

Ann Surg Oncol. 2006 Jan;13(1):36-44. Epub 2006 Jan 1.

18.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
19.

Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.

Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Eur J Surg Oncol. 2009 Aug;35(8):805-13. doi: 10.1016/j.ejso.2008.09.006. Epub 2008 Nov 28.

PMID:
19046846
20.

Are 3 sentinel nodes sufficient?

Chagpar AB, Scoggins CR, Martin RC 2nd, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, McMasters KM; University of Louisville Breast Sentinel Lymph Node Study Investigators.

Arch Surg. 2007 May;142(5):456-9; discussion 459-60.

PMID:
17515487

Supplemental Content

Support Center